Esperion Therapeutics, Inc. - COM (ESPR)

CUSIP: 29664W105

Q1 2019 13F Holders as of 31 Mar 2019

Security identity
Shares outstanding
258,506,508
Holder snapshot
Share change
+745,992
Put/Call ratio
174%
Reported price per share
$40.15
Number of holders
160
Value change
+$27,039,632
Number of buys
82
Number of sells
60

Security key

29664W105

Report period

Q1 2019

Institutions

160

Top holders

10

Ownership snapshot

Top shareholders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
BB BIOTECH AG
13D/G signal
Evidence rows
50
Latest as of
31 Dec 2018
13F Lead comparable stake: 1.3% Showing 1-8 of 50 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
BB BIOTECH AG
13F
Company
13F
1.3%
$156,076,000
3,392,964 shares
31 Dec 2018
Meditor Group Ltd
13F
Company
13F
1%
$123,272,000
2,679,835 shares
31 Dec 2018
Pentwater Capital Management LP
13F
Company
13F
0.96%
$114,416,000
2,487,300 shares
31 Dec 2018
PFM Health Sciences, LP
13F
Company
13F
0.73%
$86,434,000
1,879,003 shares
31 Dec 2018
BlackRock Finance, Inc.
13F
Company
13F
0.73%
$86,430,000
1,878,899 shares
31 Dec 2018
VANGUARD GROUP INC
13F
Company
13F
0.66%
$78,112,000
1,698,070 shares
31 Dec 2018
STATE STREET CORP
13F
Company
13F
0.58%
$69,333,000
1,507,249 shares
31 Dec 2018
Boxer Capital, LLC
13F
Company
13F
0.46%
$55,200,000
1,200,000 shares
31 Dec 2018
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
160
Shares
27,588,882
Rows loaded
160
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2019 vs Q4 2018 Across Filers

Q4 2018 holders
152
Q1 2019 holders
160
Holder diff
8
Investor Q4 2018 Shares Q1 2019 Shares Share Diff Share Chg % Q4 2018 value Q1 2019 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .